Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.28 USD | +0.19% | -2.51% | -18.08% |
06:19pm | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
02:56pm | BMO Capital Adjusts Price Target on Gilead Sciences to $80 From $89 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.08% | 82.5B | |
+25.00% | 672B | |
+24.08% | 550B | |
-6.30% | 351B | |
+15.12% | 317B | |
+7.40% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-10.26% | 144B | |
-7.34% | 141B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead Sciences : Kite Partners With Shoreline Biosciences to Develop Cancer Therapies